We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PBIO market cap is 205.59k. The company's latest EPS is USD -0.9418 and P/E is -0.01.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.81M | 1.22M | 2M | 1.73M | 1.98M |
| Operating Income | -5.81M | -4.59M | -4.19M | -4.9M | -9.5M |
| Net Income | -15.47M | -17.58M | -22.69M | -17.8M | -35.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.82M | 2.3M | 2.83M | 2.01M | 1.05M |
| Total Liabilities | 13.87M | 19.22M | 25.04M | 34.7M | 33.8M |
| Total Equity | -12.06M | -16.92M | -22.21M | -32.69M | -32.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.33M | -4.88M | -4.87M | -4.48M | -3.19M |
| Investing | -23k | -797k | -123k | -21k | -7k |
| Financing | 6.28M | 5.67M | 5.11M | 4.37M | 3.27M |
| Market Cap | 205.59k |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 4.55 |
| Price to Book Ratio | -0.01 |
| Dividend Yield | - |
| Shares Outstanding | 37.38M |
| Average Volume (1 week) | 13.69k |
| Average Volume (1 Month) | 9.04k |
| 52 Week Change | -98.88% |
| 52 Week High | 0.70 |
| 52 Week Low | 0.0007 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Pressure Biosciences Inc (CE) |
| Address |
480 neponset st., unit 10b canton, massachusetts CANTON |
| Website | https://pressurebiosciences.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
